Advertisement

Topics

MagForce AG Company Profile

07:55 EDT 24th March 2019 | BioPortfolio

MagForce AG, listed in the entry standard (MF6), together with its subsidiary MAGFORCE USA, Inc. is a leading medical device company in the field of nanomedicine in oncology. The Group's proprietary NanoTherm(R) therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm(R), NanoPlan(R), and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator are trademarks of MagForce AG in selected countries. For more information, please visit www.magforce.com.


News Articles [10 Associated News Articles listed on BioPortfolio]

MagForce (MF6) - 2019 a pivotal year

Edison Investment Research - Pharmaceutical & healthcare - MagForce: MagForce continues to implement its two-pillar strategy. A gross $9.0m capital raise secured by subsidiary MagForce USA in August w...

MagForce (MF6) - Scale Update - 2019 a pivotal year

Edison Investment Research - Pharmaceutical & healthcare - MagForce: MagForce continues to implement its two-pillar strategy. A gross $9.0m capital raise secured by subsidiary MagForce USA in August w...

Biotech Report: Evotec sacken ab, MagForce behauptet

(shareribs.com) Frankfurt / New York 07.09.2018 - Biotech-Aktien mussten am Freitag im deutschen Handel überwiegend Verluste hinnehmen. Zu den Gewinnern gehörten BioFrontera und MagForce. An der Wa....

Biotech Report: Rally bei Santhera, MagForce gesucht

(shareribs.com) Frankfurt / New York 26.02.2019 - Papiere von Santhera klettern am Dienstag in Frankfurt kräftig, auch für MagForce geht es nach oben. An der Wall Street zeigt sich derweil ein durc....

MagForce AG to host Lunch Symposium on Local Therapies for Malignant Gliomas at the 18th European Congress of Neurosurgery (EANS2018)

DGAP-News: MagForce AG / Key word(s): Conference/Miscellaneous 18.10.2018 / 09:30 The issuer is solely responsible for the content of this announcement. MagForce AG to host Lunch Symposium ...

MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland

DGAP-News: MagForce AG / Key word(s): Agreement/Alliance 21.03.2019 / 09:00 The issuer is solely responsible for the content of this announcement. MagForce AG successfully completes install...

MagForce AG MF6 Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryMagForce AG MagForce is a medical device company that offers nanotechnologybased therapy for cancer treatment. The company's products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Th...

MagForce AG MF6 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102018] Prices from USD $250

SummaryMagForce AG MagForce is a medical device company that offers nanotechnologybased therapy for cancer treatment. The company's products include NanoActivator, NanoTherm, NanoPlan and NanoTherm Th...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

MagForce AG

MagForce AG, listed in the entry standard (MF6), together with its subsidiary MAGFORCE USA, Inc. is a leading medical device company in the field of nanomedicine in oncology. The ...

MagForce Nanotechnologies AG

MagForce Nanotechnologies AG is a world-leading company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer® therapy enables the targeted destruction...

More Information about "MagForce AG" on BioPortfolio

We have published hundreds of MagForce AG news stories on BioPortfolio along with dozens of MagForce AG Clinical Trials and PubMed Articles about MagForce AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MagForce AG Companies in our database. You can also find out about relevant MagForce AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record